Position in MYO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,878
+$19,873 QoQ
Shares Held
28,730
+94.1% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 79 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,280,904,557 across 102 Medical Devices names. MYO ranks #81 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
17,260,943 | $5,434,435,284 | |
| 2 | MDT |
Medtronic plc
|
27,784,471 | $2,173,579,157 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,783,175 | $2,060,966,003 | |
| 4 | ABT |
Abbott Laboratories
|
15,095,898 | $1,369,801,775 | |
| 5 | BSX |
Boston Scientific Corp
|
23,907,838 | $1,020,386,517 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
10,329,164 | $661,169,779 | |
| 7 | PEN |
Penumbra Inc
|
1,071,454 | $338,311,597 | |
| 8 | DXCM |
Dexcom Inc
|
3,325,095 | $223,945,140 |
All Filings in MYO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,878 | 28,730 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,005 | 14,802 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $33,794 | 37,139 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $69,821 | 78,276 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $296,582 | 137,307 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $527,022 | 109,568 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $580,546 | 90,147 | Shares | Defined | 2025-02-12 | |
| 2024-06-30 | $15,404 | 4,799 | Shares | Defined | 2024-12-26 | |
| 2022-06-30 | $8 | 5 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $6,275 | 1,647 | Shares | Defined | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||